PROCEPT BioRobotics (PRCT)
(Delayed Data from NSDQ)
$71.70 USD
-0.61 (-0.84%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $71.70 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for PROCEPT BioRobotics Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -105.90 | -87.15 | -59.85 | -53.02 | NA |
Depreciation/Amortization & Depletion | 3.81 | 2.84 | 3.32 | 2.86 | NA |
Net Change from Assets/Liabilities | -26.16 | -11.49 | -4.71 | -0.48 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 20.25 | 15.42 | 3.90 | 2.30 | NA |
Net Cash From Operating Activities | -108.00 | -80.38 | -57.33 | -48.34 | NA |
Property & Equipment | -25.21 | -2.65 | -0.59 | -0.23 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -25.21 | -2.65 | -0.59 | -0.23 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 167.80 | 6.42 | 262.12 | 82.09 | NA |
Issuance (Repayment) of Debt | 0.00 | 1.20 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 24.69 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -4.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 167.80 | 3.61 | 262.12 | 106.77 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 34.59 | -79.42 | 204.19 | 58.20 | NA |
Cash at Beginning of Period | 225.67 | 305.10 | 100.91 | 42.71 | NA |
Cash at End of Period | 260.26 | 225.67 | 305.10 | 100.91 | NA |
Diluted Net EPS | -2.24 | -1.96 | -3.63 | NA | NA |
Fiscal Year End for PROCEPT BioRobotics Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -51.58 | -25.96 | -105.90 | -78.39 |
Depreciation/Amortization & Depletion | NA | 2.45 | 1.18 | 3.81 | 2.49 |
Net Change from Assets/Liabilities | NA | -13.90 | -13.70 | -26.16 | -22.66 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 15.01 | 6.19 | 20.25 | 15.35 |
Net Cash From Operating Activities | NA | -48.02 | -32.29 | -108.00 | -83.21 |
Property & Equipment | NA | -2.99 | -1.95 | -25.21 | -16.49 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -2.99 | -1.95 | -25.21 | -16.49 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 7.88 | 2.59 | 167.80 | 164.93 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 7.88 | 2.59 | 167.80 | 164.93 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -43.13 | -31.65 | 34.59 | 65.23 |
Cash at Beginning of Period | NA | 260.26 | 260.26 | 225.67 | 225.67 |
Cash at End of Period | NA | 217.13 | 228.61 | 260.26 | 290.90 |
Diluted Net EPS | NA | -0.50 | -0.51 | -0.54 | -0.51 |